





Alcohol and drug abuse cost the American workplace an estimated $100 billion per year 
in lost time (absenteeism), Workers’ Compensation claims, medical costs, lost productivity, and 
employee turnover. The workforce constitutes 75% of adults struggling with a substance use 
disorder. Employer sponsored employee treatment - which an employee is more likely to 
undergo - can save the employer up to $2,607 per worker annually.  
Contingency Management (CM), a behavioral psychosocial intervention, is among the 
most effective evidence-based approaches for Substance Use Disorder (SUD) treatment. CM 
interventions utilize a system of incentives that reward the adoption of targeted behaviors 
verified by objective measurements. Contingency Management is based on the principles of 
operant conditioning. The primary premise of operant conditioning is that external events will 
either increase or decrease the likelihood that a behavior will be repeated.   
United Parcel Service (UPS) has used CM to create a therapeutic workplace for over 20 
years with an 80% success rate for employees completing the program. The UPS program is 
similar to the cooperative employer model using continued employment as the reward. In the 
UPS program, employees are referred to a Substance Abuse Professional (SAP) for evaluation. 
The UPS occupational health nurse supervisor (OHN) along with a third party administrator 
(TPA) follow the employee through the successful completion of treatment and follow-up, or 
termination for failure to successfully complete the program. The occupational health nurse has 
proven to be valuable in the management of the program. Substance abuse is not just a personal 
problem; it effects not only the individual, but also their family, friends, co-workers and the 
employer. Therefore it is a societal problem and employers have a responsibility to the 
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communities they serve to be compliant with the law and to act in the best interest of their 
employees. Employers who implement a therapeutic workplace are giving their employees an 
opportunity to overcome a personal challenge, re-engage in the workplace and be successful. 
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The workplace can be many things: a place to earn a living, a place for social 
connections, and a therapeutic environment that promotes substance abuse abstinence. In the 
workplace, Occupational Health Nurses play critical roles in worker health and wellbeing. They 
often act as the advocate for both the worker and the employer. One area where this expertise 
comes into play is in the managing of workplace substance abuse programs, including the return-
to-duty process outlined in the Department of Transportation (DOT) Drug and Alcohol Testing 
Rules.  
Scope of the Problem  
Alcohol and drug abuse cost the American workplace an estimated $100 billion per year 
in lost time (absenteeism), Workers Compensation claims, medical costs, lost productivity, and 
employee turnover (Employment Screening Resources [ESR], 2011). Substance abuse 
contributes significantly to workplace fatalities. While many people may envision alcohol and 
substance abusers as unemployable, the research indicates otherwise, “that a majority of drug 
and alcohol abusers in the United States were employed: 75 percent of illicit drug users over 18, 
nearly 80 percent of binge and heavy drinkers, and 60 percent of adults with substance abuse 
problems” (ESR, 2011, para 1) the costs are not limited to employers and some estimate that 
“substance use disorders or addictions cost taxpayers more than $440 billion annually” (“10 
More Facts,” 2017, para 4). 
The Substance Abuse and Mental Health Services Administration (SAMSHA) tracks 
treatment admission and discharges annually. The data are analyzed over a period of years and 
reports published on various trends. These data provide researchers with a wealth of information, 
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such as the prevalence of substance use and the geographic patterns of use. Additionally the 
information demonstrates the scope of the problem among employed Americans. 
Among employed adults, the prevalence of any SUD, including alcohol use disorder, is 
8.6% nationally, ranging from Utah and Tennessee at 7.4% of 18 year olds and above, to 
Washington, DC (13.4%), Rhode Island (10.8%), and Montana (10.0%). The national 
prevalence of prescription pain medication misuse in the past 12 months is 4.2%. At the 
higher end are Arizona (5.2%), Oklahoma (5.1%), Alabama (5.0%), and Oregon (5.0%). 
At the lower end are Wyoming (3.4%), Florida (3.4%), Maine (3.4%), and Vermont 
(3.34%). (Goplerud, Hodge, & Benham, 2017)  
In 2017, the U.S. Department of Labor announced “$11.7 million dollars in grant funding to 10 
agencies to assist offenders with return to work. Substance abuse programs were listed as part of 
the support to be given to this group” (U.S. Department of Labor n.d.c, para 1). 
The list of workplace issues caused by substance abuse is endless. According to Wilcox 
(n.d.), who wrote an article on drugs and alcohol in the workplace, he stated: 
research indicates that workers with alcohol problems were 2.7 times more likely than 
workers without drinking problems to have injury-related absences. A hospital 
emergency department study showed that 35% of patients with an occupational injury 
were at-risk drinkers. Breathalyzer tests detected alcohol in 16% of emergency room 
patients injured at work. Analyses of workplace fatalities showed that at least 11% of the 
victims had been drinking. Large federal surveys show that 24% of workers report 
drinking during the workday at least once in the past year. Approximately 20% of 
workers and managers across a wide range of industries and company sizes report that a 




A DOT 2010 Report on Drug Involvement of Fatally Injured Drivers reported that in 2009, 
21,978 drivers were fatally injured in motor vehicle accidents. Over 13,801 (63%) of fatally 
injured drivers were tested for the presence of drugs, of which 3,952 tested positive for drug 
involvement. This number represents 18% of all fatally injured drivers and 29% of those with 
known drug test results. (U.S. Department of Transportation, 2010, p. 1) 
“The Drug-Free Workplace Act of 1988 requires some Federal contractors and all 
Federal grantees to agree that they will provide drug-free workplaces as a precondition of 
receiving a contract or grant from a Federal agency” (U.S. Department of Labor, n.d.a, para 1). 
Although, all covered contractors and grantees must maintain a drug-free workplace, the 
specific components necessary to meet the requirements of the Act vary based on 
whether the contractor or grantee is an individual or an organization. The requirements 
for organizations are more extensive because organizations have to take comprehensive, 
programmatic steps to achieve a workplace free of drugs. (U.S. Department of Labor, 
n.d.b, para 2) 
Employers have a unique role to play in saving lives from the devastation that substance 
abuse can cause. Employer sponsored treatment and recovery support is a win-win for businesses 
and labor. Each employee who completes a treatment program and returns to work can 
potentially save the employer up to $2,607 annually ("10 More Facts,” 2017, para 4). UPS, as a 
Federal contractor, is required to have a policy in place that meets the requirements of the Drug-
Free Workplace Act. The written policy lets employees know that UPS has a vital interest in the 
safety of their employees and the public, and that they maintain a workplace that is free from 
drugs and alcohol. Employees are informed of the Employee Assistance Program and 
encouraged to use it on a voluntary basis. UPS also informs employees that they prohibit the 
illegal possession, use, distribution, sale, dispensing, transfer or manufacturing of controlled 
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substances while at work, on company business, or company property. Employees are not 
permitted to be on duty if they possess illegal substances or alcohol or are under the influence of 
and illegal substance or alcohol, nor can they stay on duty when they may be impaired by 
unauthorized controlled substances or alcohol. The company reserves the right to have a medical 
evaluation if the employee’s behavior gives UPS reasonable cause to believe that the employee is 
impaired and in violation of the UPS drug and alcohol policy (2003) (see Appendix A). 
Emerging Issues 
Legalization of Drugs 
Legalization of drugs such as marijuana along with the current opioid crisis continues to 
cause concerns for employers.  
Nationwide, use of the drug marijuana has increased dramatically. A survey from the 
National Institutes of Health found that past-year use more than doubled between 2001 
and 2013, from 4.1 to 9.5 percent of the population, and addiction rates increased from 
1.5 to 2.9 percent of the population (Dougherty, 2016, para 10). 
Dougherty (2016) suggests that employers not covered by these federal laws need to provide 
employees with a safe workplace and should not compromise safety or productivity standards 
because of state marijuana laws. “Accidents or poor job performance due to absenteeism, 
tardiness, or insubordination do not need to be tolerated in a person using medical marijuana if 
other employees are held to the same standard” (Dougherty, 2016, para 22). In 2018, 30 states 
legalized marijuana in some form either for recreational use or for medical purposes. Ten states 
and the District of Columbia have adopted the most expansive laws legalizing marijuana for 






The ongoing opioid epidemic has had a significant impact on the workforce, especially in 
labor-intensive industries where an aging workforce often has legitimate medical pain issues that 
can lead to addiction. Today, substance use in the workplace challenges virtually all employers 
and necessitates the involvement of the occupational health nurse as part of the multi-
disciplinary team to address the issue.  Challenges include having employees with impaired 
judgement doing safety sensitive work, employees with poor reaction times, absenteeism that 
impacts employer productivity and workers burdened with additional workload, and overall 
decreased productivity of workers who are substance abusers. While the challenges are great, the 
potential benefits can be even greater.  
The UPS Drug and Alcohol Abuse Program is one example of an effective “second 
chance” substance abuse program that offers significant benefits to both the employer and the 
employee: the employer retains a valuable worker and the employee is offered a unique 
opportunity for successful recovery. Some of the most effective workplace substance use 
programs are operated by employers that are regulated by federal agencies. These programs are 
required to provide structured processes that are designed to reward abstinence and provide 
negative consequences to those who continue substance use.   
In 2017, 81% of all UPS employee referrals to rehabilitation completed their 
rehabilitation and returned to work successfully.  By comparison, nationally only 35% of 
individuals, based on employment status, successfully completed rehabilitation. Only 31% of 
those classified as not in the labor force successfully completed rehabilitation (U.S. Department 
of Health & Human Services, 2015). While the UPS program is based on the mandates of the 
Federal Motor Carrier Safety Administration (FMCSA), there are other federally mandated 
programs, such as the Human Intervention and Motivational Study (HIMS) program for pilots 
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and the Nuclear Regulatory Commission (NCR) fitness for duty and Access Authorization 
Program, which will be discussed later.  
Non-Mandated Program 
UPS also has a non-mandated substance abuse program where employees have the 
opportunity to take advantage of substance treatment administered through a TPA specific to 
DOT Substance Abuse Professional (SAP) and Substance Use Disorder evaluations.  Because of 
the large union population of the workforce, the non-mandated follow-up program mirrors that of 
the mandated program, and is covered in the collective bargaining agreement. The non-mandated 
employees have the same opportunity for rehabilitation and must enter into a rehabilitation 
agreement with the company in the same manner as the mandated employees.  The rehabilitation 
agreement outlines the responsibilities of the employee and the consequences of failure to abide 
by the agreement. 
The UPS Drug and Alcohol Rehabilitation program creates a unique opportunity for 
employees to successfully recover by offering Contingency Management program that supplies a 
reward (employment) for abstinence. It is an avenue for employees to work in a therapeutic 
environment and maintain abstinence while remaining employed. The program follows the rules 
as outlined by the FMCSA for SAP evaluation, return to work testing, and follow-up testing and 
aligns with the collective bargaining agreement. 
Purpose of Paper 
The purpose of this paper is to describe Contingency Management (CM) and how it 
applies to a therapeutic workplace. In addition, the role of the occupational health nurse will be 







Contingency Management (CM) is among the most effective evidence-based approaches 
for Substance Abuse Disorder (SUD) (Rash, Stizer, & Weinstock, 2017). CM interventions 
utilize a system of incentives that reward the adoption of targeted behaviors verified by objective 
measurements (Rash et al., 2017). 
Contingency Management is based on the principles of operant conditioning.  Operant 
conditioning was originally explored in the early 1900s by psychologist B.F. Skinner (Spielman 
et al., 2014). The primary premise is that external events will either increase or decrease the 
likelihood that a behavior will be repeated. Reinforcement is any event that increases the chance 
of the behavior recurring. Positive reinforcement is an event that is added while negative 
reinforcement is an event that is removed. Punishment is an event that decreases the likelihood of 
a behavior and it too can be positive (added) or negative (removed). An example of positive 
reinforcement is being paid for going to work (Spielman et al., 2014). An example of negative 
punishment is the loss of employment following a positive drug test.  
Schedules of reinforcement in operant conditioning is important because it has an impact 
on the effectiveness of learning. A continuous schedule of reinforcement means that behavior is 
reinforced every time it occurs, and will result in fast learning. However, when the reinforcement 
is stopped, the behavior often stops quickly. A variable ratio schedule of reinforcement means 
that the behavior is reinforced in a fluctuating pattern. Variable ratio schedules of reinforcement 
produce a high, steady response rate that is not easily stopped (Spielman et al., 2014). To 
continue with the work example, if someone was paid daily to go to work and payment abruptly 
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stopped, that person would quickly stop going to work. However, if a person was paid on a 
variable ratio schedule—sometimes weekly, sometimes monthly, sometimes every other 
month—and payment abruptly stopped, they might continue working for many weeks, even 
months, before stopping.  
Contingency Management builds upon the basic principles of operant conditioning to 
refine and design behavioral interventions. CM SUD treatment is based upon the premise that 
drug taking is susceptible to contingencies of reinforcement. In other words, the decision to use 
drugs is determined in large part by the consequences of each behavior, with the immediate 
consequences weighing much more heavily on the ultimate decision to use substances (Dallery, 
DeFulio, & Meredith, 2015; Heyman, 2009; Higgins & Silverman, 2008).  
Contingency Management and Substance Use Disorder Treatment 
 The effectiveness of the CM approach has been supported by more than 50 randomized 
controlled trials (RCTs) and hundreds of other studies. The first published description of an RCT 
of a CM SUD intervention appeared in 1975 (Miller, 1975). Other CM studies followed that 
demonstrated CM as a new and promising treatment to reduce cocaine use (Higgins et al., 1992; 
Higgins et al., 1993; Higgins et al., 1994). Since the Higgins studies in the early 1990s, over five 
dozen additional RCTs on the efficacy of CM have been published. The evidence suggests broad 
utility of the CM approach across common drugs of abuse, e.g., opiates (Robles, Stitzer, Strain, 
Bigelow, & Silverman, 2002), cocaine (Higgins et al., 1994), amphetamines (Roll et al., 2006), 
marijuana (Carroll et al., 2006), alcohol (Petry, Martin, Cooney, & Kranzler, 2000), and in a 
variety of populations, e.g., adults in typical outpatient treatment settings (Petry et al., 2005), 
adolescents (Stanger, Budney, Kamon, & Thostensen, 2009), pregnant mothers (Jones, Haug, 
Silverman, Stitzer, & Svikis, 2001), and the homeless (Milby et al., 2001). CM is effective 
whether the incentives are delivered as vouchers (Higgins et al., 1994), in prize-based systems 
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(Petry et al., 2005), or as access to employment (Silverman, DeFulio, & Sigurdsson, 2012) or 
housing (Tuten, DeFulio, Jones, & Stitzer, 2012). CM is also successful in combination with 
pharmacotherapies (Kosten et al., 2003; Silverman et al., 1996), other psychosocial approaches 
(Budney et al., 2015; Carroll et al., 2006; Higgins et al., 1993; Petry et al., 2005) or as a stand-
alone intervention (Rawson et al., 2006). Perhaps most importantly, these studies establish CM 
as effective in initiating drug abstinence and in maintaining drug abstinence over long time 
periods. Because of the broad success of CM in RCTs, there has been some headway in terms of 
disseminating the intervention to real-world clinical settings. Perhaps the biggest success to date 
is the adoption of CM procedures by the Veterans Administration (VA), which has implemented 
CM procedures at over 100 locations nationwide and received training from CM experts to guide 
implementation (Sorenson et al., 2007). However, attempts to disseminate CM through existing 
channels of outpatient substance abuse treatment providers have been slower than what would be 
expected given the plethora of research available. This discrepancy is likely due to a combination 
of lack of training, lack of funding, and ideological differences between typical drug treatment 
counselors and the CM theoretical position that drug taking is behavior is sensitive to its 
consequences (Dutra et al., 2008; Sorenson et al., 2007). 
There has been substantial research supporting the workplace as a setting for CM SUD 
treatment. Silverman, Holtyn, and Morrison (2016) reviewed the effectiveness and challenges of 
workplace applications. Their work focused on the Therapeutic Workplace at the Johns Hopkins 
University Center for Learning and Health. Three experimental models were reviewed: the social 
business model, the cooperative employer model, and the wage supplement model. Given the 
fact that the most successful CM efforts have taken place in laboratory settings, models that 
involve active participation of employers (cooperative employer and the wage supplement 
model) may have the best chance of extending CM into the workforce and establishing CM as an 
10 
 
accepted front line treatment for SUDs. Studies of long-term applications of CM that do not 
actively involve employers are not shown to have effectiveness beyond four years (Aklin et al., 
2014).  
Research Related to Contingency Management Substance Abuse Programs   
Dr. Kenneth Silverman, Professor of Psychiatry and Behavioral Sciences at the Center for 
Learning and Health at Johns Hopkins School of Medicine in Baltimore, Maryland, and leading 
researcher in CM, discussed his research in the area of the therapeutic workplace (K. Silverman, 
personal communication, June 27, 2018). His CM research program, supported by funding from 
the National Institutes of Health (NIH) grants, consists of providing a work environment for 
people enrolled in the CM program. Data entry is performed for companies affiliated with the 
CM research program. Cubicles are set-up as work areas and there are also areas for urine testing 
and blood draws. The workers in the program are put into groups with a control group, an 
abstinence group, and a medication adherence group. Progress is measured on negative drug 
screens and lab results for medication adherence. Dr. Silverman finds that relapse often occurs 
when the program is stopped. The program is often stopped due to time limits and funding 
concerns. The programs usually last for 1 to 2 years. Dr. Silverman believes that the success that 
has been seen in the UPS program aligns well with the research that he and others have 
performed. He would like to see other employers follow UPS’ lead in having a viable 
Contingency Management program in the workplace. 
Contingency Management in the Workplace 
The original applied research impetus for the use of CM to support safety in the 
workplace came from treatment programs for impaired physicians. Physician Health Programs 
(PHPs) became the template of the New Paradigm for Long-Term Recovery (Dupont & 
Humphreys, 2011) that utilized a CM protocol where impaired physicians could maintain or 
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regain licensure by complying with a zero-tolerance protocol requiring rigorous random testing, 
total abstinence from illicit substances, and a long-term follow-up test monitoring period (five 
years).  Participating physicians typically signed contracts stipulating commitment to adhere to 
protocols and acceptance of loss of licensure should they violate program parameters. These 
programs proved very effective and compelling. Dupont and Humphreys (2011) also reported on 
a sample of 904 physicians in 16 PHP programs. After five years, 72% completed their contracts 
in full compliance. Test results for this group yielded a 99.5% negative rate. Among the original 
group who entered the programs, 78% maintained licensure and were engaged in active medical 
practices, 4% retired or left medicine, 11% had their licenses revoked, and the dispositions of the 
remaining were unknown. The New Paradigm’s emphasis on using maintenance of licensure as a 
contingent incentive, contracts, rigorous testing, abstinence, and a five year follow-up period 
monitoring by continued testing remains the gold standard for employment-based SUD treatment 
(Dupont & Skipper, 2012). 
Contingency Management and the Criminal Justice System 
Criminal justice initiatives for reducing SUDs and motivating positive behaviors have 
been studied and reported as successful. Incentives included parole contingencies and sentence 
reductions. Dupont and Humphreys (2011) reported on Hawaii’s Opportunity Probation with 
Enforcement (HOPE) program a program that incorporates CM principles. HOPE participants 
are substance users who have violated probation department drug and alcohol policies, e.g., 
positive tests, missed tests, and missed probation appointments. They can opt to avoid 
incarceration and reinstate probation status by entering the HOPE program which requires 
abstinence verified by testing. The HOPE program lasts up to six years. Approximately 85% of 
HOPE participants complete the program drug and alcohol free. Dupont and Humphreys (2011) 
also described a Driving While Intoxicated program operated in South Dakota called 24/7 
12 
 
Sobriety. Arrestees are incentivized by an opportunity to avoid jail by complying with abstinence 
requirements verified by testing.  This program reported a 66% program completion success rate. 
Contingency Management: Update and Current Status 
Petry, Alessi, Olmstead, Rash, and Zajac (2017) described the current status of CM for 
SUD treatment. It delves into the pros and cons of CM for SUD treatment and points to needs for 
future research and improvements. It recognizes the strengths and abundance of supporting 
research and identifies weaknesses. Criticisms of applications of CM for SUD treatment are 
described as the philosophical differences between CM and mainstream treatment approaches.  
Petry et al. (2017) believe that many of these issues can be attributed to the fact that most CM 
studies have been confined to laboratory settings. As CM extends into workplaces where real-
world reward and incentives are provided in cooperation with employers, motivation, economics, 
and durability should be resolved. The philosophical differences may be the most difficult to 
overcome. Most treatment programs are still tied to 12 Step Community-Based treatment, e.g., 
Alcoholics Anonymous, Narcotics Anonymous (Petry, Weinstock, Alessi, Lewis, & Dieckhaus, 
2010; Templeton, Velleman, & Russell, 2010). CM, however, has been demonstrated to be 




EMPLOYER SPONSORED SUBSTANCE ABUSE PROGRAMS AS A CRITICAL 
PLAYER IN ADDRESSING WORKPLACE SUBSTANCE ABUSE 
 
Contingency Management (CM) has been demonstrated to be an effective intervention 
for substance abusers (Rash et al., 2017). However, in spite of the evidence-based success 
demonstrated in repeated studies, this intervention is not widely used by treatment providers, and 
researchers are working to find ways to increase adoption (Rash et al., 2017). Currently, 
employer-based programs designed to protect safety are one of the most common uses of CM to 
promote abstinence. In scenarios where public safety is very clearly at risk, stringent 
accountability for substance users coupled with high incentive contingencies are employed to 
good effect. Employer-based programs create a CM framework for treatment delivery and 
follow-up that maximizes the employee’s chance for success.  Occupational health nurses 
responsible for assisting with or administering mandated drug and alcohol programs have a 
unique opportunity to help individuals recover while protecting safety. Too often second 
chance/return to duty programs are regarded as “punishment,” requiring the individual to pay the 
price for bad choices by going through the motions required to regain employment. The reality, 
however, is that individual in employer mandated CM programs has a much higher likelihood of 
treatment completion than those independently seeking treatment.   
Some examples of programs include the U.S. DOT (2018) Drug and Alcohol Testing 
rules and return to duty process; the Federal Aviation Administration’s (FAA) HIMS program 
for pilots seeking special issuance of a FAA medical certificate (HIMS, n.d.), and the U.S. 
Nuclear Regulatory Commission’s (2018) fitness for duty procedures for unescorted access in a 
nuclear plant. Each program has clear guidelines and rules that form the backbone of an effective 
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employer-based Contingency Management program. By providing accountability, structure, and 
follow-up, the programs both protect public safety and provide participants with a far greater 
probability of program completion and extended substance abstinence. Each program will be 
discussed below.   
Nuclear Regulatory Commission Substance Abuse Program 
The Fitness for Duty (FDD) programs were originally established by the NRC in 1989 
(U.S. NRC, 2017b). The primary contingency on the FFD program is unescorted access within a 
nuclear plant. The goal of the substance abuse program is to ensure that the workplace is free 
from the presence and effects of drug and alcohol. However, the FFD program has a broader 
mandate to establish that individuals who are granted access are “trustworthy and reliable” (U.S. 
NRC, 2017a). 
The NRC FFD programs establish guidelines for drug and alcohol testing which are pre-
access, for cause, post event, follow-up, and random tests (U.S. NRC, 2018). The NRC FFD 
program, unlike the U.S. DOT rules, allows individual nuclear licensees to add additional drugs 
to the testing panel beyond the required 5 (marijuana, cocaine, opiates, amphetamines, 
phencyclidine) (U.S. NRC, 2018, §26.31). Individuals are referred for an evaluation by an SAE 
following a violation of the NRC drug and alcohol testing rules or following the disclosure of 
potentially disqualifying information during the authorization process either via self-disclosure 
or as the result of the suitable inquiry by the licensee (U.S. NRC, 2018). The role of the SAE in 
these cases is to protect not only public health and safety but also national security. Ultimately, 
the SAE is responsible for a making FFD determination specifically related to substance abuse. 
The requirements to be an SAE are very similar to those required by the DOT in terms of 
licensure, training on relevant regulations and continuing education (U.S. NRC, 2018). However, 
there are some critical program differences. For example a face-to-face assessment is only 
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required by NRC in the case of for-cause positive test results. Additionally, unlike the DOT 
rules, the SAE is not required to make a recommendation for education or treatment, to have a 
follow-up appointment or to make follow-up testing recommendations (U.S. NRC, 2018). In this 
way, the long-term contingencies of the FFD program differ from the DOT programs. However, 
the NRC establishes very clear contingencies for multiple policy violations. Sanctions include: 
 a permanent denial of authorization following a refusal to test;  
 5 year authorization denial following the use, possession or sale of illegal drug or 
alcohol in a protected area;  
 a 5 year denial of authorization if an individual resigns following a positive drug or 
alcohol test;  
 a minimum 14 day withdrawal of authorization for first offense positive that must 
include a FFD evaluation by an SAE; and  
 5 year denial for a second positive (U.S. NRC, 2018). 
If an individual has ever had a 5 year denial and has a subsequent rule violation, that individual 
is permanently disqualified. 
The Federal Aviation Administration and Contingency Management 
The FAA has successfully employed a CM-based program of their own called the Human 
Intervention Monitoring Study (HIMS). The maintenance of medical clearance to operate a 
commercial aircraft is used as an effective reward incentive. HIMS is a peer operated program 
requiring peer substance use identification and referral. It follows a more stringent structure than 
the DOT’s 49 CFR Part 40 program. Pilots who have an active diagnosis of a substance use 
disorder lose their FAA medical certification (FAA, 2018b).  
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Instead of referral to a DOT SAP, evaluation and program monitoring duties are 
supervised by an FAA Aviation Medical Examiner (AME), who acts as the Independent Medical 
Sponsor (IMS) (HIMS, n.d.). According to the HIMS website,  
The medical sponsor provides oversight of the pilot’s continuing care. This care includes 
a monthly interview by a trained flight manager and by a pilot peer committee member, 
as well as periodic follow-up observations. Because of the relapse potential of chemical 
dependency, the monitoring will typically continue for several years after the pilot 
resumes his duties. The HIMS program is designed to ensure the pilot maintains total 
abstinence and to protect flight safety. (HIMS, n.d., para 9)  
Each airline works within the general framework of the HIMS model to establish the specifics of 
the program.  
Once the a pilot loses his/her medical certification, the HIMS model provides for 
comprehensive medical and psychological assessment, generally followed by inpatient treatment, 
aftercare and relapse prevention, monthly ongoing sponsorship by management and peer 
sponsors, post treatment psychological and psychiatric assessment that include neurological 
assessments (HIMS, n.d.). The IMS gathers all the records and submits a full record to the 
Federal Air Surgeon for review. At that point the FAA may choose to issue the pilot a special 
issuance of the medical certificate (HIMS, n.d.). However, maintenance of the special issuance 
certificate requires ongoing monthly participation by the pilot and the sponsors until the FAA 
deems otherwise (HIMS, n.d.).   
Incentives take the form of eligibility to regain FAA medical certification as a result of 
successful program compliance.  In a paper submitted to U.S. House of Representatives in 2009, 
the Airline Pilots Association noted that the program had a 90% success rate with over 4,500 
participants ("Fiscal Year 2010 Appropriations," 2009).  
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UPS maintains one of the largest airlines in the world. The UPS HIMS program is 
overseen by a HIMS committee that includes management, union representatives, peer 
representatives, and UPS occupational health. The UPS OHN is responsible for maintaining and 
resourcing the needed medical contractors (AMEs, psychologists, psychiatrists, and treatment 
providers) to run the program smoothly. Additionally, the UPS OHN works with the TPA 
responsible for the UPS Drug and Alcohol Rehabilitation Program to maintain oversight of the 
process for each pilot.   
U.S. Department of Transportation Drug and Alcohol Testing  
Under rules of the DOT program, §40.23 specifies that covered DOT employees who 
register positive tests may maintain or become eligible for regaining safety sensitive employment 
only if they comply with treatment and return to duty protocols (U.S. DOT, 2018). For DOT 
safety sensitive employees covered under the Federal Motor Carrier Safety, mandatory testing 
begins with pre-employment testing. If hired, FMCSA employees are subject to random testing, 
post-accident testing, and reasonable-suspicion testing (Federal Motor Carrier, 2018, Tests 
Required). The U.S. DOT (2018) Procedures for Transportation Workplace Drug and Alcohol 
Testing regulations specify in §40.23 that when an employee tests positive and opts to comply 
with DOT requirements for keeping or regaining employment in the industry, the employee must 
be removed from service by the employer and successfully complete a return to duty program 
that includes extensive follow-up testing to regain and maintain employment in a DOT safety 
sensitive job role. The five classes of drugs that are tested for include marijuana, cocaine, opiates 
(opium and codeine derivatives), amphetamines and methamphetamines, and phencyclidine 
(PCP) (U.S. DOT, 2018, § 40.85). 
The U.S. DOT drug and testing rules were originally put into place in the late 1980s. The 
Omnibus Transportation Testing Act of 1991 required the U.S. DOT Operating Administrations 
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to establish drug and alcohol testing rules to protect safety (Kelly, 2014). In 2000, the final rule 
was issued that outlined the procedures for U.S. DOT mandated drug and alcohol testing as well 
as the Return to Duty process following a violation of the testing rules (Kelly, 2014). The current 
drug and alcohol testing rules are found in the Code of Federal Regulations under 49 CFR Part 
40 (U.S. DOT, 2018). The drug and alcohol testing regulations are updated regularly. An 
example includes a 2009 update requiring all return to duty and follow-up urine drug screens be 
collected via direct observation (Procedures for Transportation Workplace Drug and Alcohol 
Testing, 2009). On January 1, 2018, a final rule was published in which opiates were reclassified 
as opioids and now include hydrocodone, hydromorphone, oxycodone, and oxymorphone in 
addition to codeine, morphine, and 6-acetylmorphine (heroin) (U.S. DOT, 2017). Additionally, 
the 2018 change to the regulations requires the MRO to report a safety concern to the DER in 
cases where the result is negative because the individual has a legitimate medical explanation for 
the positive lab result, such as a valid prescription, but the medical issue could impact safety 
(U.S. DOT, 2017). 
Each U.S. DOT Operating Administration defines the following: safety sensitive duty for 
that transportation mode; the types of tests required; the annual percentages for random testing; 
and prohibited conduct (Federal Aviation Administration, 2018a; Federal Motor Carrier, 2018; 
Federal Railroad Administration, 2018; Federal Transit Administration, 2018; Pipeline Safety 
Administration Drug and Alcohol Testing. (2018); U. S. Coast Guard, 2018). Examples of safety 
sensitive duty include: 
 driving a commercial motor vehicle over 26,001 pounds under FMCSA;  
 operators, mechanics and armed security under FTA;  
 flight crew, flight attendants, and flight instructors under FAA;  
 locomotive engineers, conductors, switchmen, and train dispatches under FRA;  
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 a person performing in operation, maintenance, or emergency response function for a 
pipeline under PHMSA; or  
 a crew members on a commercially operated vessel under USCG. 
The types of tests required vary by Operating Administration and can include pre-
employment, random, reasonable cause, return to duty, and follow-up tests. Prohibited conduct 
also varies by Mode and can include positive tests, alcohol consumption within a particular time 
period before duty and refusal to test. All U.S. DOT testing required by the Operating 
Administration must be conducted with the procedures outlined in 49 CFR Part 40, which 
provide specific procedures and safeguards against fraud, misuse, and abuse for each step of the 
process. Procedures are outlined for employers, collectors, laboratories, medical review officer 
(MRO), and substance abuse professional (SAP) (U.S. DOT, 2018). 
Once an employee has had a DOT Drug and Alcohol Testing rule violation, such as a 
positive test, the employer is responsible for removing that employee from service (U.S. DOT, 
2018, §40.23). The employer is also responsible for providing that employee with a list of 
qualified SAPs locally available “with names, address, and telephone numbers” (U.S. DOT, 
2018, §40.287). To be qualified as a SAP, the clinician must meet the following credentials (U.S. 
DOT, 2018, §40.281):   
 licensed physician (Doctor of Medicine or Osteopathy);  
 licensed or certified social worker; 
 licensed or certified psychologist; 
 licensed or certified employee assistance professional; 
 state-licensed or certified marriage and family therapist; 
 drug and alcohol counselor certified by the National Association of Alcoholism and 
Drug Abuse Counselors Certification Commission (NAADAC); or by the 
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International Certification Reciprocity Consortium/Alcohol and Other Drug Abuse 
(ICRC); or by the National Board for Certified Counselors, Inc. (NBCC); 
 Knowledgeable about and have clinical experience in the diagnosis and treatment of 
alcohol and controlled substances-related disorders; 
 Completion of a U.S. DOT SAP qualification training meeting the requirements of 
Part 40; Complete an approved Qualification Exam; and complete 12 CEUS every 3 
years from the date of the qualification exam directly related to issues impacting SAP 
practice; and  
 Subscribe to the Office of Drug and Alcohol Policy and Compliance (ODAPC) 
listserv.  
In the most simplified terms, once the employee has been removed from service 
following a rule violation, there is a three step process that must be met: 
1. face-to-face evaluation with a qualified SAP,  
2. compliance with the recommended treatment/education, and  
3. follow-up face-to-face follow-up evaluation with the SAP. 
The purpose is to determine if the employee is in compliance with the SAP’s recommendations 
and eligible for a return to duty by the employer (U.S. DOT, 2009). The SAP also outlines an 
individualized follow-up testing schedule prescribing a minimum of 6 tests in the first year 
following return to duty up to 5 years post return to duty (U.S. DOT, 2009).    
The U.S. DOT Return-to-Duty program has been credited with driving down positive test 
rates and supporting public transportation safety (Morrison & DuPont, 2013). The authors 
attributed the program’s success to the utilization of CM principles: drug use was punished by 
suspension or termination, and abstinence was rewarded by eligibility to continue or resume 
employment. According to Morrison & DuPont (2013), employment, as an incentive, 
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represented a high enough magnitude of reward value to successfully compete with drug and 
alcohol use. About 13.6% of the U.S. DOT workforce tested positive in 1988 (Quest 
Diagnostics, 2018). In 1991, when mandatory testing was introduced, 8.8% tested positive; in 
2001, 4.6% tested positive; and in 2016, 4.2% registered positive tests (Quest Diagnostics, 
2018). 
UPS Drug and Alcohol Rehabilitation Program 
The UPS Drug and Alcohol Rehabilitation Program is based on the U.S. DOT 
requirements for employees performing safety sensitive jobs, and is similar to the cooperative 
employer model (Silverman et al., 2016). Employees working in safety sensitive jobs who have a 
positive drug or alcohol screen or who seek assistance voluntarily due to dependence on 
controlled substances or alcohol are entered into the CM program. The UPS Drug and Alcohol 
Rehabilitation Program provides a rehabilitation opportunity for both U.S. DOT mandated 
employees and non-federally mandated drivers. The program is administered by the UPS OHN 
working directly with a Third Party Administrator (TPA), specific to the U.S. DOT SAP process, 
which is distinct from the EAP ensuring that appropriate boundaries are maintained. The UPS 
Drug and Alcohol Rehabilitation Program is governed by a rehabilitation agreement that outlines 
the contingencies inherent in the program (see Appendix B).   
The employee is referred by the UPS OHN to the UPS TPA who assists with ensuring the 
SAP evaluation is completed timely. Referrals to the program are required when a UPS 
employee: 
 Has had a U.S. DOT positive test result for drug or alcohol, 
 Is a U.S. DOT mandated employee and self refers to the company, 




 Is a Non-Mandated Driver who receives a Driving Under the Influence (DUI) or 
Driving While Intoxicated (DWI) citation on personal time, or 
 Has a request for an evaluation by a U.S. DOT doctor. 
The UPS employee contacts the TPA and is assigned to a case manager. The TPA case 
manager has an intake call with the employee to determine what type of evaluation is needed. If 
the employee is in crisis, the case manager may assist the employee to go directly to treatment, 
delaying the evaluation process until after the immediate crisis has been addressed. The TPA 
maintains a network of U.S. DOT qualified SAPs around the country. A local provider is 
contacted and an evaluation appointment is set up within 2 days of the referral to the TPA. The 
UPS OHN receives on-going communication from the TPA case manager and works directly 
with UPS Labor Relations to address any issues that might arise during the process.    
At the face-to-face evaluation, the SAP conducts a comprehensive assessment of the 
employee’s clinical needs for assistance, as directed by the DOT regulations (U.S. DOT, 2009). 
The SAP will make a recommendation for the level of care and provide information to the 
employee regarding treatment/education resources.  The TPA is also available to provide support 
to both the evaluator and the employee during the recommendation process. Referral information 
is communicated to the UPS OHN along with potential time lines for return to duty. Once the 
employee has complied with the recommendations to the satisfaction of the SAP, the TPA case 
manager sets up a face-to-face follow-up evaluation during which the SAP will determine the 
employee’s compliance with the recommendation and make recommendations for a follow-up 
testing plan. 
Upon completion of the evaluation and the recommended treatment program, the UPS 
OHN and the TPA work toward a successful return-to-work process. The TPA arranges for the 
employee to have the return-to-work drug, and alcohol test, while the UPS OHN arranges the 
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return-to-work conference with the employee and his/her management team. During this 
conference, the terms of return-to-work, as outlined in the UPS Rehabilitation Agreement, are 
reviewed with the employee (see Appendix B). These terms include remaining drug and alcohol 
free, complying with any follow-up treatment that is recommended by the SAP, and 
understanding that there will be follow-up testing performed which could last up to 5 years.  
After passing the return-to-work drug and alcohol screen, the employee returns to work 
and begins follow-up testing. The TPA and UPS OHN continue to follow the case and confer 
with the SAP when needed for concerns with the employee’s compliance. UPS has been doing 
CM for over 20 years with an 80% success rate for program completion. The ability to maintain 
employment has proven to be a significant reward for UPS employees. 
The UPS Drug and Alcohol Rehabilitation Program impacts many lives and requires 
tremendous effort and coordination by the UPS OHN. According to the annual report provided to 
UPS by the TPA in 2017, 714 referrals to the program were made and as of June 2018, there 
were 1,155 UPS employees participating in the program (see Appendix C). In 2017, 67% of all 
referrals were related to alcohol. Only 4% were related to opioids (see Appendix C). From 
January to May 2018 (five months), the percentage of opioid referrals increased from 4% to 8% 
(see Appendix C). As seen with many of the Contingency Management programs discussed, 
success rates are high with 81% of all UPS referrals to the program successfully completing the 
program and returning to work (see Appendix C). After 2 years in the program, over 75% 
continue to be successful (see Appendix C). 
Organizing and maintaining the appropriate HIPAA compliant releases, navigating 
various applicable state and federal laws, ensuring vendor standards, and coordinating with UPS 
Labor Relations Managers are all critical pieces for program success that rest with the UPS 
OHN. The development and success of the UPS Drug and Alcohol Rehabilitation Program, in 
24 
 
helping UPS employees while protecting public and workplace safety, is result of years of hard 




THE VALUE OF OCCUPATIONAL HEALTH NURSES IN MANAGING 
WORKPLACE SUBSTANCE ABUSE PROGAMS 
 
Role of the Occupational Health Nurse 
 The breadth of the Occupational Health Nurse (OHN) role in workplace substance abuse 
programs may vary from acting as a clinician and performing testing to managing a workplace 
substance abuse program with all of its facets including CM. The American Association of 
Occupational Health Nurses (AAOHN) Standards of Occupational and Environmental Health 
Nursing (2012) guide how OHNs should practice in the workplace. There are 11 professional 
standards that range from assessment to ethics. OHNs use the standards to guide practice and can 
be better positioned to fulfill the role as it relates to a workplace substance abuse program. 
Regardless of position the OHN has or the role that is being performed, it is essential to know the 
legal implications of the position, adhere to professional conduct, and know the expectations of 
the organization in regards to a workplace substance abuse program (Rogers, 2003). The OHN 
has many roles in the workplace and include clinician, case manager, health promotion specialist, 
manager, educator, researcher, and consultant (Randolph, 2003). The roles that most closely 
align with a workplace substance abuse program are clinician, case manager, manager, educator, 
and consultant. Each of these will be discussed. 
Clinician 
OHNs who are involved in workplace substance abuse programs as a clinician generally 
perform the tasks involved in the program. There are instances where the OHN is the sole onsite 
professional at a location and has to be knowledgeable and certified in all aspects of the 
substance abuse program and processes. The OHN will need to be familiar with the basics of 
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workplace drug and alcohol testing. According to the Drug and Alcohol Testing Industry 
Association (DATIA), 
drug testing works best when implemented based on a clear, written policy that is shared 
with all employees, along with employee education about the dangers of alcohol and drug 
abuse, supervisor training on the signs and symptoms of alcohol and drug abuse, and an 
Employee Assistance Program (EAP) to provide help for employees who may have an 
alcohol or drug problem (Smith, n.d. para 1).  
Employers who have drug testing programs that are regulated by the federal government and 
have employees who fall under those mandates, are required to test employees under different 
circumstances, such as: 
 random, meaning at different times and without notice,  
 pre-employment before being placed in a safety sensitive position,  
 reasonable suspicion when there is belief that an employee may be impaired,  
 post-accident if the requirements are met,  
 return to duty after a positive test, and  
 follow-up testing schedule after a positive test.  
If the program is not regulated by a federal agency, the employer may require drug 
testing for other reasons:  
 deter employees from abusing alcohol and drugs,  
 prevent hiring of individuals who use illegal drugs,  
 promote early intervention through use of EAP,  
 provide a safe workplace for employees,  
 protect the general public, and  
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 instill consumer confidence that employees are working safely and benefit from 
Workers’ Compensation Premium Discount programs (Smith, n.d. para 2).   
The OHN working in a clinical setting ensures the technical aspects of getting a drug and alcohol 
screen completed, whether conducting the actual testing or overseeing the program and being 
accountable for program compliance. When acting as a clinician in the drug testing program, the 
OHN plays an important role in the testing process, including obtaining consent to perform the 
test, overseeing the collection, and labeling of test samples (Morgan, 2016). Obtaining consent 
indicates that the employee understands and gives permission to perform the test. Properly 
completing the documentation associated with the specimen is very important as it can be used to 
contest any positive test results. Therefore, the OHN ensures that the documentation is complete, 
correct, and retained. These same processes apply to breath alcohol testing as well. The OHN or 
person performing the test is required to be a certified breath alcohol technician to perform the 
breath alcohol test (BAT). With a wide breath of clinical knowledge, the OHN is able help the 
employee understand the effects of substance abuse on the individual and family members.   
 Case Manager 
The OHN as a case manager in a workplace substance abuse program works in a similar 
way to that of a case manager for an injured worker. The OHN follows the nursing process by 
conducting an assessment of the situation. The nurse interviews the employee and may 
communicate with the employee’s management team under certain circumstances. This 
interview and gathering of other information allows the OHN to formulate a diagnosis and plan 
which would include referral of the employee to a treatment program for assistance which is the 
implementation phase of the process. During the assessment phase the OHN can also identify 
barriers that may be present that could potentially interfere with the employee’s successful 
completion of the program. If barriers are identified, the OHN is able to communicate those to 
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the treatment professional. Follow-up with the employee is key after the referral is made to 
assess if the employee is compliant with recommendations for treatment and that the employee 
feels the treatment program is meeting his/her needs. The OHN then follows the employee’s case 
through treatment and assists with the return-to-work process. Through communication with the 
employee and follow-up with all parties involved, the OHN is able to evaluate the success of the 
intervention.  
Additionally, documentation is also an important part of the OHN’s responsibilities. In a 
workplace substance abuse program, some of those documents include the follow-up testing 
schedule and assurance that the testing schedule meets the requirements of the regulations. 
Because of the potential for relapse in substance abuse cases, evaluation is an ongoing process. 
Any signs of relapse could lead to the employee losing his/her ability to perform safety sensitive 
work which could lead to loss of employment.  
Manager 
The occupational health nurse’s role as a manager within the workplace substance abuse 
program is one of a program manager. The OHN has the expertise and influence within the 
organization to establish the parameters by which the program will run and the services that will 
be provided. In addition, the nurse also sets the quality standards and manages vendors to meet 
those standards. Through the quality assurance process, the OHN is able to audit those vendors 
and providers to ensure that these standards are met and maintained. In a substance abuse 
program that contains CM, there is additional cost to the organization above the cost of the 
normal EAP. As the program manager, the OHN is responsible for building the business case to 
support the use of CM which should include the potential return on investment (ROI) to the 
organization, demonstrating business acumen and an understanding that cost is a factor that has 
to be addressed. By running an effective CM program, the OHN has an impact to the 
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organization in many areas. One of these areas is employee turnover which has a cost to the 
employer of hiring and training new employees. When the CM program has successful outcomes 
in terms of return-to-work by employees in the program as well as maintenance of abstinence, 
the employer has qualified individuals to perform the work with a reduction in costs associated 
with hiring new employees. These statistics can be measured and used to document the success 
of the program to the organization.  
Another aspect of program management is to maintain the confidentiality of the program 
in accordance with the Health Insurance Portability and Accountability Act (HIPAA). Under the 
privacy rule, an individuals’ health information must be properly protected while allowing the 
flow of health information needed to provide health care. It allows for the use of important 
information while protecting the individual’s privacy (HHS Office of the Secretary, Office for 
Civil Rights, & OCR, 2013, para 2). Under this provision, the OHN is able to communicate with 
the employee and providers to ensure that both the employees and employers concerns are 
addressed. Maintaining the proper confidentiality of the program impacts the organization by 
reducing the potential litigation costs associated with breaches in confidentiality. Showing that 
confidentiality is maintained is also important if the organization’s program is tied to a collective 
bargaining agreement. Along with not violating HIPAA, the program manager must ensure that 
the provisions under the American’s with Disabilities Act are adhered to as well. Although an 
employee who is actively involved in any type of substance abuse is not covered under the Act, 
those employees who are seeking treatment or have been treated have protection under the Act. 
The OHN manager needs to be aware of what this provisions are and have the ability to work 






The educator role as it relates to the substance abuse program is unlike the role of an 
educator in academia in that the education takes place within the organization. The OHN, as part 
of the multi-disciplinary health and safety team, is responsible for educating the team on the 
facets of the substance abuse program. Education of management about CM is important because 
it provides the understanding and the guidelines surrounding the program. The OHN has an 
integral part in the development of training and communication regarding the program which 
contains information on how to identify the signs and symptoms of impairment and how to refer 
employees for assistance.  
The management team needs to understand the roles and responsibilities to provide the 
guidance necessary to know when and under what circumstances it is required by law to perform 
a drug test on an employee. As the educator, the occupational health nurse must stay abreast of 
changes in regulations and make updates to the program based on these changes. Working 
collaboratively with other functions within the organization such as human resources (HR), labor 
relations, operations, and risk management, the OHN ensures adherence to program processes 
and procedures, and communicates changes in regulations that have an impact on the program. 
For example, in January of 2018, the U.S.DOT expanded the drug testing panel to include 
opioids. This change required updates to educational material for both management and 
employees, as well as the communication of changes to the workplace.  
Another key component educator role is the relationship with the employees who require 
assistance. The OHN is able to use program knowledge as well as nursing knowledge to assist 
the employees. The nurse acts also as an advocate for both the employee and the employer. 
Vendor and other healthcare professional education is important in a workplace substance abuse 
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program. The OHN should be the primary contact and provide information about the 
organizational culture, structure, policies, and procedures that makes the program successful.   
Consultant 
 The OHN as a consultant in a workplace substance abuse program works as an internal 
resource for the organization. As with case management, the OHN follows the nursing process of 
problem assessment, problem diagnosis as a result of the assessment, planning a course of action 
or education required, implementation of the plan, and continuous evaluation of the processes 
and program. While the OHN may not have the in-depth knowledge of all business areas, the 
OHN is able to provide support to other functions impacted by the substance abuse program and 
share nursing expertise and knowledge on the topic. Because of this, the OHN is seen as the 
subject matter expert (SME). This is exemplified by guidance given to HR on pre-employment 
testing procedures and the requirement to place an employee into a safety sensitive position as 
outlined by the regulations. With OHN support, the HR professional is able to have knowledge 
on proper hiring practices for safety sensitive positions. The operations supported by the OHN 
look for guidance in understanding the circumstances under which the employee is subject to 
drug and alcohol testing. Assistance is given to management to aid in understanding when drug 
and alcohol testing is required, and to act as a conduit between management and the employee 
and the employee and providers. Working with labor relations, the OHN is able to provide 
guidance on drug and alcohol testing regulations and how those regulations apply to the 
collective bargaining agreement. This support helps to make bargaining over program 
requirements easier for labor managers who may not understand how to apply the regulations in 
the workplace. This support provided to non-occupational health professionals in the workplace 





Another perspective that should be addressed in the role of the OHN is ethics. The 
AAOHN has an established a Code of Ethics (AAOHN, 2016) that refers to the OHN as the 
person who provides care with regard to client’s rights, protects confidential information, 
protects a client from unethical and illegal actions, and uses individual judgement while 
complying with the appropriate laws and regulations (AAOHN, 2016; Rogers, 2003). The OHN 
can be confronted with situations daily that challenge the ethics by which the substance abuse 
program is run. The nurse can be put under pressure from employees who find themselves in an 
undesirable situation, from management looking for information that they are not entitled to 
have, and by other outside influences. To resolve situations like these, the OHN must use ethical 
decision making by understanding the situation, getting others involved, and coming up with the 
right course of action as it relates to each situation. 
Rationale for OHN Program Manager as DER  
 A requirement of the U.S. DOT is that the employer designate a Designated Employer 
Representative (DER). The DER is an employee authorized by the employer to take immediate 
action(s) to remove employees from safety-sensitive duties, or cause employees to be removed 
from these covered duties, make required decisions in the testing and evaluation processes, and 
receive test results and other communications for the employer. Although it is not required by the 
U. S. DOT for the DER to be a healthcare professional, the OHN’s skill set is one that is well 
suited for this role in an organization. Some of the skills that the OHN possesses are: the 
knowledge of the regulations that govern the substance abuse program, the understanding of 
human behavior as it relates to a person who is a substance abuser, knowledge of other laws that 
have an impact on the program such as HIPAA and the ADA for instance. The DER role is 
multifaceted and one with great responsibility within an organization.  
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Legal and Ethical Challenges to Drug Testing 
 Workplace drug testing is not without controversy. Some argue that random urine drug 
screens do not demonstrate current impairment; that the tests are not reliable; and that testing 
constitutes an unconstitutional search and seizure (American Civil Liberties Union [ACLU], 
n.d.). However, the general trends in the federal courts uphold random testing in jobs impacting 
public safety; those requiring firearms; and those with highly classified information (ACLU, 
n.d.). Other types of testing such as pre-employment, reasonable suspicion, and post-accident are 
more common. State laws vary widely in types of workplace drug testing allowable. Best 
practices in a well-designed drug testing program should include: provision of written notice to 
both applicants and employees of drug testing policy including the types of testing, procedures, 
and consequences; required signed consent form acknowledging understanding of the policy; 
policy stating how results are verified and how results may be challenged; policy should ensure 
employee confidentiality; and the policy should have a release of liability form from the 
administration or use of the test (General Counsel, PC, Attorneys at Law, n.d.). 
 However, even the most well-designed drug testing program will face challenges in the 
coming years with the ever-shifting landscape regarding marijuana legalization. Federal law 
currently still prohibits the use and sale of marijuana; however, state laws legalizing both 
medical and recreational marijuana abound, creating confusion and litigation for employers 
(Miller, & Farnsworth, 2017) 
In the U.S. DOT drug testing world, the Office of Drug and Alcohol Policy and 
Compliance (ODAPC) has taken a strong stance prohibiting the use of marijuana by DOT 
covered safety sensitive employee regardless of state laws (Swart 2009; Swart, 2012). The 
Medical Review Officer is charged with verifying every DOT drug test result, positive or 
negative (U.S. DOT, 2018, §40.123). The verification process includes an employee interview 
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with the employee in which that employee has the opportunity to present his or her case for a 
legitimate medical explanation of the lab result (U.S. DOT, 2018, §40.135). In the case of a 
cannabis positive, (U.S. DOT 2018, §40.151) is very clear that a recommendation for the 
medical marijuana does not constitute a legitimate medical explanation. In January 2018, the 
U.S. DOT drug and alcohol testing regulations, 49 CFR Part 40, were amended to clarify the 
definition of the word “prescription” to align with the federal Controlled Substances Act (CSA) 
(U.S. DOT, 2017). The CSA specifically prohibits the prescription of a Schedule 1 drug, which 
includes marijuana. Therefore, while most states issue a “card” on the recommendation of a 
physician to allow the use of medical marijuana, that card is not a “prescription” and may not be 
considered by the MRO when verifying a test result. The MRO may order additional testing to 
rule out the use of Marinol, a prescription cannabinoid that is not a schedule 1 drug and is 
regulated by the FDA) (U.S. DOT, 2017).   
 For the non-federally regulated employers, however, risks abound. Employers risk 
charges of negligence in hiring and maintaining potentially dangerous employees if they turn a 
blind eye to marijuana use in the workplace and yet face the risk of litigation related to disability 
law if they take action (Miller & Farnsworth, 2017). In states with medical marijuana, SSDI 
claims rose 9.9% after legalization (Miller, 2018).  
 Marijuana legalization is in its infancy and the impact on society is unknown. The long-
term effects of marijuana use on general health and cognition remain to be seen. THC levels in 
marijuana have risen in the past 30 years from about 10% to 30-50% (Miller & French, 2018). 
Washington and Colorado were among the earliest states to pass legalization measures and the 
statistics are grim. Marijuana traffic-related deaths went from “55 in 2013 to 125 in 2016” 
(Miller & French, 2018, para 7).  Use of marijuana by young people increased by 12% in the 3 
years since recreational legalization (Miller & French, 2018). Crime in Colorado increased 11% 
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from 2013 (the year recreational marijuana was passed) to 2016 (Miller & French, 2018). The 
promised tax boon was only 0.8% of the state’s annual budget (Miller & French, 2018). While 
66% of local jurisdictions banned medical and recreational marijuana businesses, in June 2017, 
there were 491 retail marijuana stores in Colorado compared to 392 Starbucks and 208 







 Contingency Management has been around for decades and has been researched 
extensively with multiple studies conducted on its effectiveness. These studies have concluded 
that CM works not only in industry but in other areas when support has been maintained. UPS 
has had a CM program in place for over 20 years in both the ground transportation arena and in 
the airline, and has been able to benefit from the success of both programs. Highly skilled 
workers in safety sensitive positions have been retained while lowering turnover rates and 
reducing hiring costs. 
In today’s competitive labor market, employers have to look for ways to hire and retain 
quality employees. Barriers to achieving that are, the current opioid crisis that has placed 
stressors in the workplace, and increased legalization of marijuana in many states. With these 
barriers the Federal regulations support the use of CM programs in the workplace evidenced by 
certain requirements contained in the regulations. Today’s political landscape is moving more 
towards less regulation in many areas of industry, however, with the high stakes of public safety 
in the balance recent regulatory changes have moved toward strengthening regulations that 
impact public safety instead of loosening.  
Raising awareness among employees about the impact of substance use on performance, 
and offering the appropriate resources and/or assistance to employees in need, will not 
only improve worker safety and health, but also increase workplace productivity and 
market competitiveness. (U.S. Department of Labor, n.d.b, para 4) 
When there is a comprehensive program in place that includes education, testing, training, and 
access to treatment and support, the result can be a win-win situation for both the employee and 
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employer. The value of a therapeutic workplace is seen by allowing the employer to retain 
employees who have for one reason or another found themselves in need of assistance. The 
employee is able to continue employment and provide for themselves and their family.  
The occupational health nurse plays a significant role in both the success of the program 
for the employer as well as the employee. Organizational support for the program is also a key to 
success, and the ability of the OHN to develop a compelling business case for CM in the 
workplace that is based on cost benefit analysis, workplace trend, and the regulatory landscape 
helps to maintain that support or potentially grow the program. This type of research done by the 
OHN and shared with others in benchmarking sessions could lead to more organizations 
adopting a CM program.  
There are many opportunities to potentially expand CM beyond the federally mandated 
programs, and use with other employee groups in hopes of retaining employees. CM could also 
have a place outside of the workplace for parents who are looking for ways to support children 
who have become addicted.  Rewards such as privileges or monetary compensation could be 
used with a child or young adult in the same manner as with a worker. Because of the support 
that parents are willing to give children for long periods of time, CM could prove to be very 
beneficial for this group as well. 
When all parties involved come together and work toward a successful resolution, CM 
can have a positive impact on society as a whole.  
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UPS DRUG ALCOHOL POLICY 
  
 
UPS Drug Alcohol Policy 
At UPS we have a vital interest in the safety of our employees and the general public. 
By maintaining the highest standards for our employees we ensure the efficient and 
safe operations necessary to provide reliable services to our customers. It is well 
recognized that individuals who use illicit drugs or abuse alcohol are more likely to have 
workplace accidents, incur greater amounts of lost time, and perform their job 
requirements in a substandard manner. 
There is an even greater concern at United Parcel Service because of the nature of 
our service. Therefore, it is our intent to continue to promote a safe and secure work 
environment free of illicit drugs and alcohol abuse or use. 
We maintain a drug-free and alcohol-free workplace. We maintain an Employee 
Assistance Procedure to help our employees who may be suffering from substance 
abuse. Any employee may volunteer for this service. Our Employee Assistance 
Procedure assures that employees who develop drug or alcohol problems will have 
access to medical evaluation and appropriate community-based treatment. 
We prohibit the illegal possession, use, sale, distribution, dispensing, transfer, or 
manufacturing of a controlled substance or alcohol while at work, company property, or 
while on company business. No employee is permitted to go on duty or remain on duty 
if he or she possesses or has the presence of an unauthorized controlled substance or 
alcohol in their system. In addition, employees are not permitted to go on duty or 
remain on duty if they may be impaired by the presence of an authorized controlled 
substance. 
We also require, if necessary, a fitness-for-duty medical evaluation any time an 
employee, by his or her actions or behavior, gives UPS reasonable cause to 
determine whether an employee has violated the UPS Drug and Alcohol Policy. 
United Parcel Service will comply with all U.S. Department of Transportation rules 
and regulations concerning controlled substances and alcohol testing for 
government mandated classifications of employees. 
I have read, understand and have been provided a copy of the UPS Drug and 
Alcohol Policy and agree to abide by its terms. 
*Contact District/Region Occupational Health management regarding the Employee Assistance 
Procedure (EAP) at:  _______  -  _________  . 







UPS/IBT ALCOHOL AND/OR DRUG REHABILITATION AGREEMENT 
 
 
I, ___ _  ________, agree that, in consideration of this alcohol and/or drug rehabilitation 
opportunity and as a condition of continuing employment with United Parcel Service, I shall do 
the following: 
1. I shall voluntarily submit to a return-to-work alcohol/drug test so that the Substance Abuse 
Professional (SAP) may ensure that I am alcohol and/or drug free. 
2. I shall voluntarily submit to unannounced alcohol/drug testing, as determined by the SAP, 
who may consult with the MRO regarding drug test-related issues and the aftercare treatment 
professional. 
3. I understand that all alcohol/drug testing under this rehabilitation program shall be conducted 
pursuant to Article 35 of the National Master United Parcel Service Agreement and 
applicable laws and regulations. 
4. I shall remain drug and alcohol free upon my return-to-work.  I agree to attend aftercare 
treatment programs as outlined by my aftercare treatment professional and the SAP, for the 
period of time recommended.  If requested, I will send documentation of my attendance at 
such aftercare program to the SAP.  I also authorize the SAP to verify my participation and 
progress.  If available, a copy of the Aftercare Treatment Plan will be attached to this 
agreement. 
 
I understand that the following will result in my discharge from United Parcel Service: 
1. Failure to successfully complete rehabilitation, or 
2. Any positive specimen, or 
3. Failure to comply with the SAP’s recommendations or aftercare treatment program. 
 
X_________________________________ ___________________________________ 




















UPS COHN ANNUAL REPORT: DRUG AND ALCOHOL REHABILITATION 
PROGRAM, JUNE 26, 2018 
 
 
Total Employee Referrals by Year 
 
 UPS Referrals 
◦ Total 2017 = 714 
o Y/Y 6% Increase  
◦ Total 2016 = 672 
◦ Total 2015 = 660 
◦ Total 2014 = 646 
◦ Total 2013 = 628 
 
 Referrals Year To Date 
◦ January – May 2018 = 356 
o Y/Y 19% Increase 
◦ January – May 2017 = 298  
◦ January – May 2016 = 289 
◦ January – May 2015 = 305 
◦ January – May 2014 = 269 
◦ January – May 2013 = 282 
 
Employee Referrals by Region 
 
East Region Referrals  
 
 Total Year Referrals 
◦ Total 2017 = 206 
o Y/Y 3% Decrease 
◦ Total 2016 = 213 
◦ Total 2015 = 222 
◦ Total 2014 = 189 
◦ Total 2013 = 184 
 
 Referrals Year To Date 
◦ January – May 2018 = 110 
◦ January – May 2017 = 87 
◦ January – May 2016 = 91 
◦ January – May 2015 = 105 
◦ January – May 2014 = 80 






Central Region Referrals 
 
 Total Year Referrals 
◦ Total 2017 = 232 
o Y/Y 15% Increase 
◦ Total 2016 = 202 
◦ Total 2015 = 182 
◦ Total 2014 = 189 
◦ Total 2013 = 160 
 
 Referrals Year To Date 
◦ January – May 2018 = 112 
◦ January – May 2017 = 92  
◦ January – May 2016 = 87 
◦ January – May 2015 = 92 
◦ January – May 2014 = 80 
◦ January – May 2013 = 78 
 
West Region Referrals 
 
 Total Year Referrals 
◦ Total 2017 = 223 
o Y/Y 19% Increase 
◦ Total 2016 = 188 
◦ Total 2015 = 201 
◦ Total 2014 = 219 
◦ Total 2013 = 229 
 
 Referrals Year To Date 
◦ January – May 2018 = 109 
◦ January – May 2017 = 94  
◦ January – May 2016 = 82 
◦ January – May 2015 = 92 
◦ January – May 2014 = 96 
◦ January – May 2013 = 108 
 
Other (CACH, Freight, Cartage, SCS, Air, Air 22-65) 
 
 Total Year Referrals 
◦ Total 2017 = 52 
o Y/Y 8% Decrease 
◦ Total 2016 = 61 
◦ Total 2015 = 54 
◦ Total 2014 = 42 
◦ Total 2013 = 51 
 
 Referrals Year To Date 
50 
 
◦ January – May 2018 = 24 
◦ January – May 2017 = 25  
◦ January – May 2016 = 28 
◦ January – May 2015 = 16 
◦ January – May 2014 = 13 




 Referrals Year To Date 
◦ January – May 2018 = 1 
◦ January – May 2017 = 1 
◦ January – May 2016 = 3 
◦ January – May 2015 = 0  
◦ January – May 2014 = 2 
◦ January – May 2013 = 1 
 
Total Active Cases in ASAP program  
 
Note that cases remain in aftercare and testing anywhere from 1-5 years – total includes 
all cases currently active regardless of year opened. 
 
 UPS active cases as of June 11, 2018 = 1155 
◦ In SAP process prior to RTW= 263 
◦ Testing and aftercare program = 892 
 East = 348 
 Central = 335 
 West = 362 
 Other = 110 
 
Substances Referred For: 
 
January – December 2017: Below is the primary substance employees were abusing.  
However, 13% of employees admitted to poly substance abuse. 
1. Alcohol = 67% 
2. Cannabis = 17% 
3. Cocaine = 4 % 
4. Amphetamine = 3% 
5. Opiates = 3% 
6. Expanded Opiates= 1% 
7. Prescription Drugs = <1% 
8. Sub Oxone= <1% 
9. Unknown = 4% (Due to refusal to test or case closed prior to SAP evaluation.) 
 
January – May 2018: Below is the primary substance employees were abusing.  
However, 10% of employees admitted to poly substance abuse. 
1. Alcohol = 63% 
2. Cannabis = 16% 
51 
 
3. Opiates = 8% 
4. Amphetamine = 5% 
5. Cocaine = 4% 
6. Benzodiazepines= <1% 
7. PCP = <1% 
8. Sub Oxone= <1% 
9. Synthetic Marijuana=<1%  
10. Unknown = 3% (Due to refusal to test or case closed prior to SAP evaluation.) 
 
Reason for Referral 
  
January – December 2017: 
1. DWI = 50% 
      (45% of DWI referrals required treatment for substance dependence) 
2. Self-Referral = 21% 
3. DOT Positive Test = 8% 
4. Non-DOT Positive Test = 7% 
5. Management Referral = 4% 
6. DOT Physical = 3% 
7. Refusal to Test= 2% 
8. Unknown/Other = 5%  
 
January – May 2018: 
1. DWI = 42% 
(44% of DWI referrals required treatment for substance dependence) 
2. Self-Referral = 29% 
3. DOT Positive Test = 11% 
4. Non-DOT Positive Test = 10% 
5. Management Referral = 5% 
6. DOT Physical = 2% 
7. Refusal to Test= <1% 




January – December 2017: 
 Substance Abuse Treatment - 55% of UPS referrals 
 75% of treatment referrals successfully RTW  
 4% still participating in rehabilitation 
 
 Individual Substance Abuse Counseling – 17% of UPS referrals 
 86% of individual counseling referrals successfully RTW  




 Substance Abuse Education – 28% of UPS referrals 
 85% of education referrals successfully RTW 
52 
 
 3% still participating in rehabilitation 
 
January – May 2018: 
 Substance Abuse Treatment - 54% of UPS referrals 
 27% of treatment referrals successfully RTW  
 69% still participating in rehabilitation   
 Individual Substance Abuse Counseling – 17% of UPS referrals 
 52% of individual counseling referrals successfully RTW 
 43% still participating in rehabilitation  
 Substance Abuse Education – 29% of UPS referrals 
 58% of education referrals successfully RTW 
 33% still participating in rehabilitation 
 
 
Rehabilitation and Return to Duty Success Rates 
 
 In 2017, 81% of all UPS referrals completed their rehabilitation and returned to work 
successfully. In 2018, to date 52% of all referrals completed their rehabilitation and 
returned to work successfully (39% are still in the SAP process). 
 
 By comparison, nationally only 35% of people in outpatient substance abuse 
treatment will successfully complete a program. Nationally, people in an employer 
sponsored program had the highest rates of completion (49%). (SAMHSA, Office of 
Applied Studies, Treatment Episode Data Set, 2005) 
 
 ASAP strives to help UPS employees recover by providing exceptional evaluation, 
referral and case management services. 
 
 
Success Rates in Testing and Aftercare  
 
 Of UPS employees who completed rehabilitation and started testing and aftercare in 
2015, 77% remained successful after 2 years in the ASAP program. 
 
◦ 63% successfully completed their aftercare and testing 
◦ 14% continue to successfully participate in the aftercare and testing program. 
 
 Of the 23% of 2015 employees who were not successful: 
 
◦ 12% were separated from employment as the result of a violation of the 
UPS/IBT rehabilitation agreement  
◦ 6% were separated from employment for reasons unrelated to the SAP process 
◦ 4% of 2015 aftercare cases were closed because the employee quit or retired  
◦ >1% are deceased  
◦ >1% was closed due to OHS request.  
